5-177090796-C-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_213647.3(FGFR4):c.407C>T(p.Pro136Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.77 in 1,613,588 control chromosomes in the GnomAD database, including 481,410 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_213647.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.746 AC: 113370AN: 151876Hom.: 42756 Cov.: 31
GnomAD3 exomes AF: 0.801 AC: 201070AN: 251148Hom.: 81471 AF XY: 0.802 AC XY: 108830AN XY: 135724
GnomAD4 exome AF: 0.772 AC: 1128836AN: 1461594Hom.: 438595 Cov.: 61 AF XY: 0.774 AC XY: 563070AN XY: 727102
GnomAD4 genome AF: 0.747 AC: 113490AN: 151994Hom.: 42815 Cov.: 31 AF XY: 0.753 AC XY: 55975AN XY: 74310
ClinVar
Submissions by phenotype
Classic Hodgkin lymphoma Benign:1
- -
FGFR4-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at